ORIGINAL ARTICLE
Impact of clinical characteristics on human chorionic gonadotropin regression after molar pregnancy
Allison A. GockleyI,II,
, Lawrence H. LinIII,V, Michelle DavisI,II, Alexander MelamedII,IV, Anthony RizzoI,II, Sue Yazaki SunV, Kevin EliasI,II,VI,VII, Donald P. GoldsteinI,II,VI,VII, Ross S. BerkowitzI,II,VI,VII, Neil S. HorowitzI,II,VI,VII
Corresponding author
I Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, USA
II Department of Obstetrics, Gynecology & Reproductive Biology, Harvard Medical School Boston, MA, USA
III Department of Pathology, NYU School of Medicine, New York, USA
IV Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Massachusetts, USA
V Centro de Doencas Trofoblasticas, Departamento de Obstetricia e Ginecologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR
VI Gynecologic Oncology Program, Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute/Harvard Cancer Center, Boston, USA
VII Trophoblastic Tumor Registry, New England Trophoblastic Disease Center, Boston, USA
Read
1184
Timeswas read the article
415
Total PDF
769
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 July | 7 | 8 | 15 |
| 2024 June | 47 | 57 | 104 |
| 2024 May | 56 | 21 | 77 |
| 2024 April | 45 | 27 | 72 |
| 2024 March | 49 | 25 | 74 |
| 2024 February | 104 | 28 | 132 |
| 2024 January | 61 | 30 | 91 |
| 2023 December | 30 | 33 | 63 |
| 2023 November | 54 | 36 | 90 |
| 2023 October | 62 | 44 | 106 |
| 2023 September | 39 | 44 | 83 |
| 2023 August | 36 | 12 | 48 |
| 2023 July | 48 | 25 | 73 |
| 2023 June | 34 | 6 | 40 |
| 2023 May | 33 | 0 | 33 |
| 2023 April | 10 | 2 | 12 |
| 2023 March | 8 | 2 | 10 |
| 2023 February | 5 | 1 | 6 |
| 2023 January | 4 | 3 | 7 |
| 2022 December | 25 | 9 | 34 |
| 2022 November | 12 | 2 | 14 |
Show all